A director at EDP Renovaveis SA sold 10,111 shares at 9.790EUR and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
UCB announced positive Phase 3 results for Fintepla in treating CDKL5 deficiency disorder (CDD), a rare and severe early-onset epileptic condition with limited treatment options. The randomized, placebo-controlled study in patients aged 1–35 met its primary and secondary endpoints, showing a significant reduction in countable motor seizures and a favourable safety profile. UCB plans to announce the full dataset at an upcoming conference and seek regulatory approval promptly. This marks Fintepla'...
We are 28% above cons. US Bimzelx sales for H125 with Bimzelx sales momentum being the most important factor for the UCB investment thesis. Unlike the early days for US obesity, this is one of the most complex dynamics we have contended with when forecasting sales. There are multiple unknowns that we have sought to model (net price per scrip, net avg. price by indication, 2024 volume, volume growth by payer & incremental discounts to unlock that volume growth). As a result of our analysis, we in...
A director at SEB SA sold 550 shares at 79.750EUR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Clo...
BUREAU VERITAS: Combined Shareholders’ Meeting of June 19, 2025: All submitted resolutions were adopted PRESS RELEASE Neuilly-sur-Seine, France – June 19, 2025 Combined Shareholders’ Meeting of June 19, 2025:All submitted resolutions were adopted The Combined Shareholders’ Meeting of Bureau Veritas (the "Company"), chaired by Mr. Laurent Mignon, Chairman of the Board of directors, was held today at the Company’s head office. All resolutions submitted to the Shareholders’ Meeting were adopted at a large majority, including: The approval of the statutory and consolidated financial state...
BUREAU VERITAS : Assemblée générale mixte du 19 juin 2025 : Adoption de l'ensemble des résolutions proposées COMMUNIQUÉ DE PRESSE Neuilly-sur-Seine, France – 19 juin 2025 Assemblée générale mixte du 19 juin 2025 :Adoption de l'ensemble des résolutions proposées L’Assemblée générale mixte de Bureau Veritas (la « Société ») s’est réunie aujourd'hui au siège social sous la présidence de Laurent Mignon, Président du Conseil d’administration. Toutes les résolutions soumises au vote de l’Assemblée Générale ont été adoptées à une large majorité, dont notamment : L’approbation des comptes so...
Seb a bouclé hier le placement d’une obligation de 500 m EUR qui arrivera à échéance en juin 2030. L’IPT a ouvert à « ms+185bp area », puis la guidance a été abaissée à « ms+155bp area », et au final, les titres ont été placés à ms+150bp (coupon 3.625%, reoffer 99.556%). Les leads ont indiqué avoir reçu près de 2.1 mds EUR d’ordres en book. Nous démarrons le suivi de ces nouvelles obligations SKFP 30 avec une recommandation Neutre (conserver), le pricing final étant quasiment à notre fair value...
Seb Yesterday, Seb completed the placement of a €500m bond maturing in June 2030. The IPT opened at “ms+185bp area,” then guidance was lowered to “ms+155bp area,” and ultimately the bonds were placed at ms+150bp (coupon 3.625%, reoffer 99.556%). The leads reported that they had received nearly €2.1bn in orders. We are initiating coverage of these new SKFP 30 bonds with a Neutral (hold) recommendation, as the final pricing is virtually in line with our fair value. In our view, Seb has an Invest...
Bureau Veritas accelerates its LEAP | 28 strategy execution and evolves its Executive Committee PRESS RELEASE Paris – June 18, 2025 Bureau Veritas accelerates its LEAP | 28 strategy execution and evolves its Executive Committee , a global leader in Testing, Inspection, and Certification services (TIC) is accelerating the execution of its LEAP | 28 strategy to reach its vision of being the preferred partner for its customers’ excellence and sustainability. Taking LEAP | 28 to the next level, Bureau Veritas is evolving the structure of its executive committee to drive greater organization...
Bureau Veritas accélère l'exécution de sa stratégie LEAP | 28 et fait évoluer son Comité exécutif COMMUNIQUE DE PRESSE Paris – 18 juin 2025 Bureau Veritas accélère l'exécution de sa stratégie LEAP | 28 et fait évoluer son Comité exécutif , leader mondial des services de Test, d'Inspection et de Certification (TIC), accélère l'exécution de sa stratégie LEAP | 28 pour atteindre sa vision d'être le partenaire privilégié de ses clients dans leur quête d’excellence et de durabilité. Ouvrant le prochain chapitre de LEAP | 28, Bureau Veritas fait évoluer la structure de son Comité exécutif pour...
Seb is returning to the bond market with an offering of € 500m five-year notes which will be used to refinance the SKFP 1.375% 2025 notes due on 16 June 2025. Although the group is a regular issuer of commercial paper and schuldschein debt, it rarely taps the bond market and does not have an issuer rating with S&P, Moody's or Fitch. The new bond offering will therefore be "priced" as "non-rated" and should therefore offer a premium over rated comparable bonds.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.